Clinical Trial Update: Impaired HDL and Coronary Artery Disease in Anabolic Androgenic Steroid Users

View source ↗

Summary

Clinical trial update highlighting impaired HDL and coronary artery disease in users of anabolic androgenic steroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Coronary Artery Disease | Status: COMPLETED